Clincosm LogoSign in Get a demo

Chronic Myelomonocytic Leukemia

Showing NaN - NaN of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United

Active, not recruiting
Has Results
  • Chronic Myelomonocytic Leukemia
  • +6 more
  • Birmingham, Alabama
  • +297 more
Jan 28, 2023

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 23, 2023

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +28 more
Nov 18, 2022

Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in

Completed
  • Acute Myeloid Leukemia
  • +5 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2021

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral

Completed
  • Myelodysplastic Syndrome
  • +2 more
  • Gilbert, Arizona
  • +12 more
Jun 15, 2021

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in United States (ASTX727 + Day 2 Food, ASTX727 + Day 4 Food)

Completed
  • Myelodysplastic Syndromes
  • +2 more
  • ASTX727 + Day 2 Food
  • ASTX727 + Day 4 Food
  • Buffalo, New York
  • +3 more
Feb 16, 2020

Acute Myeloid Leukemia, Alkylating Agent-Related Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Buffalo

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 16, 2020

Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +99 more
  • fludarabine phosphate
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 30, 2019

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +77 more
  • fludarabine phosphate
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 16, 2019

Chronic Myelomonocytic Leukemia, de Novo MDS, MDS Trial in Buffalo, London, Toronto (sunitinib malate)

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • sunitinib malate
  • Buffalo, New York
  • +3 more
Jul 27, 2018

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Adult Acute

Completed
Has Results
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +14 more
  • Scottsdale, Arizona
  • +233 more
Dec 8, 2016

Chronic Myelomonocytic Leukemia Trial in Buffalo, Portland, Salt Lake City (5-Azacitidine)

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • Buffalo, New York
  • +2 more
May 10, 2016